Fate Therapeutics, Inc. (FATE)
NASDAQ: FATE · Real-Time Price · USD
0.960
+0.033 (3.58%)
At close: Mar 11, 2025, 4:00 PM
0.940
-0.020 (-2.08%)
After-hours: Mar 11, 2025, 6:55 PM EST
Fate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 11, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 110 | 188 | 369 | 980 | 5,587 | 7,933 | |
| Market Cap Growth | -49.04% | -49.04% | -62.39% | -82.45% | -29.57% | 436.26% | |
| Enterprise Value | -84 | -10 | 124 | 586 | 5,018 | 7,530 | |
| Last Close Price | 0.96 | 1.65 | 3.74 | 10.09 | 58.51 | 90.93 | |
| PS Ratio | 8.01 | 13.79 | 5.80 | 10.18 | 100.05 | 252.37 | |
| PB Ratio | 0.34 | 0.59 | 1.00 | 2.03 | 8.23 | 20.64 | |
| P/TBV Ratio | 0.59 | 0.59 | 1.00 | 2.03 | 8.23 | 20.64 | |
| EV/Sales Ratio | - | - | 1.95 | 6.09 | 89.85 | 239.54 | |
| Debt / Equity Ratio | 0.27 | 0.27 | 0.28 | 0.23 | 0.17 | 0.25 | |
| Asset Turnover | 0.03 | 0.03 | 0.10 | 0.12 | 0.07 | 0.07 | |
| Quick Ratio | 7.39 | 7.39 | 8.13 | 4.17 | 7.70 | 5.73 | |
| Current Ratio | 7.58 | 7.58 | 8.48 | 4.40 | 7.79 | 5.78 | |
| Return on Equity (ROE) | -54.21% | -54.21% | -37.76% | -48.46% | -39.90% | -55.11% | |
| Return on Assets (ROA) | -25.81% | -25.81% | -19.65% | -23.69% | -17.57% | -17.31% | |
| Return on Capital (ROIC) | -27.90% | -27.90% | -22.36% | -27.79% | -21.27% | -21.25% | |
| Earnings Yield | -169.33% | -99.11% | -43.64% | -28.73% | -3.80% | -2.19% | |
| FCF Yield | -112.37% | -65.77% | -37.53% | -28.94% | -3.82% | -0.56% | |
| Buyback Yield / Dilution | -15.52% | -15.52% | -1.64% | -2.19% | -15.01% | -20.82% | |
| Total Shareholder Return | -15.52% | -15.52% | -1.64% | -2.19% | -15.01% | -20.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.